(Q38122566)

29 August 2017

Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics (English)

1 reference

familial Mediterranean fever

29 August 2017

1 reference

1 reference

6

P Portincasa

1 reference

29 August 2017

I Grattagliano

1

1 reference

29 August 2017

L Bonfrate

2

1 reference

29 August 2017

V Ruggiero

3

1 reference

29 August 2017

G Scaccianoce

4

1 reference

29 August 2017

G Palasciano

5

1 reference

29 August 2017

language of work or name

English

0 references

publication date

18 July 2013

1 reference

Clinical Pharmacology & Therapeutics

29 August 2017

1 reference

29 August 2017

95

1 reference

29 August 2017

1

1 reference

29 August 2017

89-97

1 reference

Familial mediterranean Fever in the world

29 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Hereditary periodic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a "heterozygote advantage" in Turkey?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The PYRIN connection: novel players in innate immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Criteria for the diagnosis of familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Hereditary periodic fever and reactive amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Familial Mediterranean fever. A survey of 470 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Diagnostic value of bone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The infevers autoinflammatory mutation online registry: update with new genes and functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Infevers: an evolving mutation database for auto-inflammatory syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

INFEVERS: the Registry for FMF and hereditary inflammatory disorders mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Update on colchicine and its mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Properties of the protein subunit of central-pair and outer-doublet microtubules of sea urchin flagella

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The role of interleukin-1 and the inflammasome in gout: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Crystal-induced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine phosphorylation in human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Colchicine in clinical medicine. A guide for internists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Colchicine therapy for familial mediterranean fever. A double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

21 January 2018

Colchicine update: 2008.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

21 January 2018

Colchicine: 1998 update.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Colchicine intoxication: Clinical pharmacology, risk factors, features, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

A novel mutation in the albumin gene (c.1A>C) resulting in analbuminemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

IL-1β biological treatment of familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra--case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Treatment of familial Mediterranean fever with anakinra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Cytokine traps: multi-component, high-affinity blockers of cytokine action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Canakinumab induces remission in a patient with resistant familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Efficacy and safety of biologic treatments in Familial Mediterranean Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Transmission of familial Mediterranean fever mutation after bone marrow transplantation and successful treatment with anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

Familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Plasma levels of colchicine after oral administration of a single dose

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragments

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2013.148

7 January 2021

Identifiers

DOI

10.1038/CLPT.2013.148

1 reference

29 August 2017

1 reference